Prevention of human papillomavirus (HPV) infection and cervical cancer in China: how does HPV vaccination bring about benefits to Chinese women?

X Liu, A Feng, Y Cui, RG Tobe - Bioscience trends, 2013 - jstage.jst.go.jp
Cervical cancer is the second leading cause of cancer deaths among women in the world
and more than 85% of cervical cancer cases occur in women living in developing countries …

Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia

JF Shi, YL Qiao, JS Smith, B Dondog, YP Bao, M Dai… - Vaccine, 2008 - Elsevier
To develop a comprehensive intervention policy for future management of cervical cancer in
China and Mongolia, it is essential to review the prevalence of human papillomavirus (HPV) …

[HTML][HTML] Cervical cancer prevention through HPV vaccination in low-and middle-income countries in Asia

ZQ Toh, PV Licciardi, FM Russell… - Asian Pacific Journal …, 2017 - ncbi.nlm.nih.gov
Cervical cancer is ranked the first or second most common cancer in women of low-and
middle-income countries (LMICs) in Asia. Cervical cancer is almost exclusively caused by …

Opportunities and challenges for human papillomavirus vaccination in China

C Zhao, Y Zhao, J Li, M Li, Y Shi… - Human Vaccines & …, 2024 - Taylor & Francis
Current estimates of the HPV infection rate in China vary by geographic region (9.6–23.6%),
with two age peaks in prevalence in women≤ 20–25 years of age and 50–60 years of age …

The epidemiological situation of human papillomavirus infection among women in China

S Wei, Z Tao, Z Tie-jun, Z Gen-ming - 中华疾病控制杂志, 2017 - zhjbkz.ahmu.edu.cn
Cervical cancer has caused heavy social and economical burden to our country and
worldwide. Human papillomavirus (HPV), especially the high-risk type, is closely associated …

Review of the cervical cancer disease burden in mainland China

J Li, LN Kang, YL Qiao - Asian Pac J Cancer Prev, 2011 - journal.waocp.org
Human papillomavirus (HPV) infection is a common sexually transmitted infection (STI)
worldwide. HPVmay cause several reproductive tract diseases and cervical cancer is the …

Immunogenicity, efficacy, and safety of human papillomavirus vaccine: data from China

M Li, C Zhao, Y Zhao, J Li, L Wei - Frontiers in Immunology, 2023 - frontiersin.org
The incidence rate and mortality rate of cervical cancer have steadily increased in young
women in China. Therefore, it is critical to improve HPV vaccination rates, particularly for the …

HPV prevalence and genotyping in the cervix of Chinese women

SM Wang, J Li, YL Qiao - Frontiers of medicine in China, 2010 - Springer
The role of human papillomavirus (HPV) as an etiologic factor of cervical cancer has been
firmly established, and prophylactic vaccines are now available and have been approved in …

Current experience in HPV vaccination in China

L Wang, Y Zhong, J Di - Indian Journal of Gynecologic Oncology, 2021 - Springer
China only recently introduced HPV vaccines, and HPV vaccination is yet to be included in
the National Immunization Plan. This article offers an overview of current experience in HPV …

Epidemiological features of Human Papillomavirus (HPV) infection among women living in Mainland China

J Li, R Huang, JE Schmidt, YL Qiao - Asian Pacific Journal of …, 2013 - koreascience.kr
Cancer of the cervix is the third most common cancer in women worldwide, more than 85%
of the cases occurring in developing countries such as China. In China, since a national …